Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Savara Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Savara Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Savara Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Savara Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Savara Inc., Medical Devices Deals, 2010 to YTD 2016 | 9 | 1 |
| Savara Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
| Savara Inc., Pharmaceuticals &Healthcare, Deal Details | 11 | 15 |
| Venture Financing | 11 | 1 |
| Savara Pharma Raises USD20 Million in Series C Financing Round | 11 | 1 |
| Savara Pharma Raises Additional USD5.5 Million in Financing Round | 12 | 1 |
| Savara Pharma Raises USD4.5 Million in Financing Round | 13 | 1 |
| Savara Pharma Raises US$14 Million In Series B Financing | 14 | 2 |
| Savara Pharma Raises Additional USD0.04 Million in Financing Round | 16 | 1 |
| Savara Pharma Raises Additional USD0.06 Million in Financing Round | 17 | 1 |
| Partnerships | 18 | 1 |
| Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII | 18 | 1 |
| Licensing Agreements | 19 | 1 |
| NobelPharma Enters into Licensing Agreement with Savara | 19 | 1 |
| NobelPharma Enters into Licensing Agreement with Serendex Pharma | 20 | 1 |
| Equity Offering | 21 | 1 |
| Serendex Pharma Raises USD12.7 Million Rights Offering of Shares | 21 | 2 |
| Serendex Pharma Completes IPO for USD11 Million | 23 | 2 |
| Acquisition | 25 | 1 |
| Savara Pharma Acquires Serendex Pharma | 25 | 1 |
| Savara Inc. - Key Competitors | 26 | 1 |
| Key Employees | 27 | 1 |
| Locations And Subsidiaries | 28 | 1 |
| Head Office | 28 | 1 |
| Other Locations &Subsidiaries | 28 | 1 |
| Appendix | 29 | 1 |
| Methodology | 29 | 1 |
| About GlobalData | 29 | 1 |
| Contact Us | 29 | 1 |
| Disclaimer | 29 | 1 |